Home » Newsletters » BioWorld Science

BioWorld Science

May 3, 2005

View Archived Issues

Kynurenine 3-monooxygenase: a therapeutic target for Huntington disease

ZK-EPO active against bone metastases in breast cancer

Promising results reported with a lingual spray formulation of alprazolam

Data from the HERA study support the use of Herceptin in early breast cancer

Updated survival data reported from phase I study of IL13-PE38QQR

Phase I gene therapy study for Parkinson's nears completion

ImmuFact IMP-321 enters phase I/II trials

Elixir licenses growth hormone secretagogue from BMS

GSK will not negotiate HER-2 Protein AutoVac vaccine deal

Seattle Genetics and MedImmune form antibody-drug conjugate collaboration

Semafore presents new in vivo data on SF-1126

Model proposed to explain the species-specific effects of SB-497115

Cranberry juice constituents display antiinfluenza potential

EP-2306 and EP-2302 demonstrate lipid-lowering potential in vitro

Update on the efficacy of rosuvastatin in hypercholesterolemia

Triglyceride levels have no effect on the benefits of rimonabant in overweight/obese patients

A drospirenone/estradiol combination decreases blood pressure in high-risk hypertensive women

Prous Science presents key webcast coverage of the 96th Annual Meeting of the AACR

FDA approval for Byetta

Zostavax BLA submission

Celera Genomics submits IND for CRA-024781

Supplemental NDA filed for Tarceva in pancreatic cancer

Fatty acids improve visual function in infants

Novel antiinfective agents claimed in recent patent literature

New treatments for hepatitis disclosed by Genelabs and Enanta

Recent patents describe new treatments for respiratory disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...